Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 7,543 | 3,578 | 4,658 | 30,605 | 61 |
| Gross Profit | 7,543 | 3,578 | 4,658 | 30,605 | 61 |
| Operating Expenses | 32,091 | 55,122 | 80,821 | 77,197 | 65,727 |
| Operating Income | -24,548 | -51,544 | -76,163 | -46,592 | -65,666 |
| Interest Expense | 2,399 | 1,758 | 425 | 0 | 0 |
| Other Income | 1,830 | 67 | 500 | 1,197 | 3,525 |
| Pre-tax Income | -25,117 | -53,235 | -76,088 | -45,395 | -62,141 |
| Net Income Continuous | -25,117 | -53,235 | -76,088 | -45,395 | -62,141 |
| Net Income | $-25,117 | $-53,235 | $-76,088 | $-45,395 | $-62,141 |
| EPS Basic Total Ops | -0.28 | -0.63 | -0.92 | -0.55 | -0.75 |
| EPS Basic Continuous Ops | -0.28 | -0.63 | -0.92 | -0.55 | -0.75 |
| EPS Diluted Total Ops | -0.28 | -0.63 | -0.92 | -0.55 | -0.75 |
| EPS Diluted Continuous Ops | -0.28 | -0.63 | -0.92 | -0.55 | -0.75 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.63 | -0.43 | -0.55 | -0.75 |
| EBITDA(a) | $-23,889 | $-49,967 | $-74,829 | $-46,080 | $-65,393 |